Since Tregs are supposed to suppress NK activity tumoral, Tregs (tTreg) identified as CD4+CD25hiFoxp3+ cells, were evaluated in 26 RCC patients (13 VHL-WT and 13 VHL-MUT). The gene discussed is VHL; the disease is renal cell carcinoma.